Siren »

Design Therapeutics shares owned by Siren

Quarter-by-quarter ownership of Design Therapeutics (DSGN) shares owned by Siren from 13F filings

Historical chart of Siren investment in Design Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Design Therapeutics held by Siren consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Design Therapeutics by Siren

Quarter filed Position value Share count Share price at filing
2026-06-30 $7.6M 523k 14.47

More positions owned by Siren

Scholar Rock Hldg Corp (SRRK)
Kymera Therapeutics (KYMR)
Erasca (ERAS)
Veradermics Common Stock (MANE)
Tango Therapeutics (TNGX)
Revolution Medicines (RVMD)
Bicara Therapeutics (BCAX)
Arrowhead Pharmaceuticals (ARWR)
BeOne Medicines Sponsored Ads (ONC)
Edgewise Therapeutics (EWTX)
Rhythm Pharmaceuticals (RYTM)
Lexicon Pharmaceuticals Com New (LXRX)
Enliven Therapeutics (ELVN)
Spyre Therapeutics Com New (SYRE)
Parabilis Medicines

View all positions for Siren

Top funds holding Design Therapeutics

Sr One Capital Management
Logos Global Management
Baker Bros. Advisors
Driehaus Capital Management
BlackRock
Caption Management
Point72 Asset Management
Trails Edge Capital Partners
Frazier Life Sciences Management
Vivo Capital
Vanguard Capital Management
Almitas Capital
Geode Capital Management
Sofinnova Ventures
FMR

View all funds holding Design Therapeutics